OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Study on inhibition of Britannin on triple-negative breast carcinoma through degrading ZEB1 proteins
Hong Lu, Zhengyu Wu, Yijun Wang, et al.
Phytomedicine (2022) Vol. 104, pp. 154291-154291
Closed Access | Times Cited: 7
Hong Lu, Zhengyu Wu, Yijun Wang, et al.
Phytomedicine (2022) Vol. 104, pp. 154291-154291
Closed Access | Times Cited: 7
Showing 7 citing articles:
Britannin as a novel NLRP3 inhibitor, suppresses inflammasome activation in macrophages and alleviates NLRP3-related diseases in mice
Jingjing Shao, Weifeng Li, Jinfeng Sun, et al.
Acta Pharmacologica Sinica (2024) Vol. 45, Iss. 4, pp. 803-814
Closed Access | Times Cited: 15
Jingjing Shao, Weifeng Li, Jinfeng Sun, et al.
Acta Pharmacologica Sinica (2024) Vol. 45, Iss. 4, pp. 803-814
Closed Access | Times Cited: 15
Britannin inhibits cell proliferation, migration and glycolysis by downregulating KLF5 in lung cancer
Ying Wang, YU Bo-tao, Mengyuan Qu, et al.
Experimental and Therapeutic Medicine (2024) Vol. 27, Iss. 3
Open Access | Times Cited: 4
Ying Wang, YU Bo-tao, Mengyuan Qu, et al.
Experimental and Therapeutic Medicine (2024) Vol. 27, Iss. 3
Open Access | Times Cited: 4
Natural Products as Novel Therapeutic Agents for Triple-Negative Breast Cancer: Current Evidence, Mechanisms, Challenges, and Opportunities
Qingzhou Li, Zhen Ye, Guilin Wang, et al.
Molecules (2025) Vol. 30, Iss. 6, pp. 1201-1201
Open Access
Qingzhou Li, Zhen Ye, Guilin Wang, et al.
Molecules (2025) Vol. 30, Iss. 6, pp. 1201-1201
Open Access
Exploring mechanisms of britannin against colorectal cancer based on experimentally validated network pharmacology
Xiaoli Liu, Qiuxia Ye, Mengdi Hao, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Xiaoli Liu, Qiuxia Ye, Mengdi Hao, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Research progress on antitumor mechanisms and molecular targets of Inula sesquiterpene lactones
Fei Cao, Chu Chu, Jiang‐Jiang Qin, et al.
Chinese Medicine (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 5
Fei Cao, Chu Chu, Jiang‐Jiang Qin, et al.
Chinese Medicine (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 5
Britanin – a beacon of hope against gastrointestinal tumors?
Agnieszka Kajdanek, Damian Kołat, Lin-Yong Zhao, et al.
World Journal of Clinical Oncology (2024) Vol. 15, Iss. 4, pp. 523-530
Open Access
Agnieszka Kajdanek, Damian Kołat, Lin-Yong Zhao, et al.
World Journal of Clinical Oncology (2024) Vol. 15, Iss. 4, pp. 523-530
Open Access
Mechanism Actions of Coniferyl Alcohol in Improving Cardiac Dysfunction in Renovascular Hypertension Studied by Experimental Verification and Network Pharmacology
Qiuling Wu, Qilong Zhou, Chengyu Wan, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 10063-10063
Open Access
Qiuling Wu, Qilong Zhou, Chengyu Wan, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 10063-10063
Open Access
